Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Aadi Bioscience: Q2 Earnings Insights

  Aadi Bioscience (NASDAQ:AADI) reported its Q2 earnings results on Wednesday, August 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
August 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Aadi Bioscience (NASDAQ:AADI) reported its Q2 earnings results on Wednesday, August 10, 2022 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Aadi Bioscience beat estimated earnings by 8.0%, reporting an EPS of $-0.69 versus an estimate of $-0.75.

Revenue was up $3.44 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 10.83% increase in the share price the next day.

 

To track all earnings releases for Aadi Bioscience visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Reported Late Wednesday, Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information And Announces Its Net Asset Value And Asset Coverage Ratios At January 31, 2023; Net Assets Were $1.4B And Its Net Asset Value Was $10.32/Sh…

By Happy Mohamed
February 2, 1:54 AM
 Kayne Anderson Energy Infrastructure Fund, Inc. (the "Company") (NYSE:KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage

KYN